| Editor's Choice: Heart Failure | Researchers completed an updated analysis of the SPRINT study, sharing their results in the New England Journal of Medicine. Researchers completed an updated analysis of the SPRINT study, sharing their results in the New England Journal of Medicine. | | |
| This Class I recall covers more than 130,000 different devices, according to the FDA. This Class I recall covers more than 130,000 different devices, according to the FDA. | | |
| Researchers explored data from the GALACTIC-HF trial to evaluate how the severity of a patient's reduced ejection fraction impacts the benefits of omecamtiv mecarbil. Researchers explored data from the GALACTIC-HF trial to evaluate how the severity of a patient's reduced ejection fraction impacts the benefits of omecamtiv mecarbil. | | |
| The authors evaluated data from more than 2.1 million patients, sharing their findings in Circulation. The authors evaluated data from more than 2.1 million patients, sharing their findings in Circulation. | | |
| “Our findings suggest that cardiologists should consider the value of regular psychological assessments, especially among younger patients,” one researcher said. The team's full findings will be presented at ACC.21. “Our findings suggest that cardiologists should consider the value of regular psychological assessments, especially among younger patients,” one researcher said. The team's full findings will be presented at ACC.21. | | |
| The TAP-CHF trial is expected to enroll up to 100 AFib patients with a history of HFpEF. The TAP-CHF trial is expected to enroll up to 100 AFib patients with a history of HFpEF. | | |
| Low levels of residual mitral regurgitation after TEER can make a big impact on patient outcomes, researchers explained in a new analysis. Low levels of residual mitral regurgitation after TEER can make a big impact on patient outcomes, researchers explained in a new analysis. | | |
| The study's authors explored data from two different clinical trials, focusing on patients with HFrEF and HFpEF. The study's authors explored data from two different clinical trials, focusing on patients with HFrEF and HFpEF. | | |
| The full analysis is scheduled to be presented May 16 at ACC.21. The full analysis is scheduled to be presented May 16 at ACC.21. | | |
| Researchers examined heart failure mortality from 1999 to 2017, detailing some of the many trends they uncovered in the Journal of the American Heart Association. Researchers examined heart failure mortality from 1999 to 2017, detailing some of the many trends they uncovered in the Journal of the American Heart Association. | | |
| |
|
| ![]() | |
|
